Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihisa Kitamura

Showing results (11-20 of 251) with videos related to

Pageof 26
Sort By:
Biological & Pharmaceutical Bulletin|March 27, 2002
Antiparkinsonian drugs and their neuroprotective effectsYoshihisa Kitamura, Jun-Ichi Kakimura, Takashi Taniguchi
Trends in Molecular Medicine|August 21, 2003
Disease model: Parkinson's diseaseShun Shimohama, Hideyuki Sawada, Yoshihisa Kitamura, et al.
Journal of Natural Medicines|June 22, 2026
Hochuekkito reversed poly(I:C)-induced anxiety-like behavior and reductions in hippocampal BDNF expression in miceTeppei Ueda, Yasuhisa Izushi, Soichiro Ushio, et al.
Biological & Pharmaceutical Bulletin|May 2, 2017
DJ-1/PARK7: A New Therapeutic Target for Neurodegenerative DisordersMasanori Hijioka, Masatoshi Inden, Daijiro Yanagisawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 3, 2012
[Development of advanced educational programs, including research programs, for undergraduate students in National Universities: the facts in 2010]Yuji Kurosaki, Yoshihisa Tomioka, Tomofumi Santa, et al.
Journal of Pharmaceutical Health Care and Sciences|January 29, 2016
Effectiveness of medical supportive team for outpatients treated with sorafenib: a retrospective studyMakoto Kajizono, Megumu Aoyagi, Yoshihisa Kitamura, et al.
Brain Sciences|February 25, 2022
Lipoxin A<sub>4</sub> Receptor Stimulation Attenuates Neuroinflammation in a Mouse Model of Intracerebral HemorrhageRisa Futokoro, Masanori Hijioka, Moe Arata, et al.
Acta Medica Okayama|August 27, 2020
Immobility-reducing Effects of Ketamine during the Forced Swim Test on 5-HT1A Receptor Activity in the Medial Prefrontal Cortex in an Intractable Depression ModelKei Takahashi, Yoshihisa Kitamura, Soichiro Ushio, et al.
Pharmacology, Biochemistry, and Behavior|March 20, 2002
Effects of imipramine and lithium on wet-dog shakes mediated by the 5-HT2A receptor in ACTH-treated ratsYoshihisa Kitamura, Hiroaki Araki, Katsuya Suemaru, et al.
Neurochemical Research|May 10, 2003
Neuroprotective mechanisms of antiparkinsonian dopamine D2-receptor subfamily agonistsYoshihisa Kitamura, Takashi Taniguchi, Shun Shimohama, et al.
Pageof 26

Showing results (11-20 of 251) with videos related to

Sort By:
Pageof 26
Biological & Pharmaceutical Bulletin|March 27, 2002
Antiparkinsonian drugs and their neuroprotective effectsYoshihisa Kitamura, Jun-Ichi Kakimura, Takashi Taniguchi
Trends in Molecular Medicine|August 21, 2003
Disease model: Parkinson's diseaseShun Shimohama, Hideyuki Sawada, Yoshihisa Kitamura, et al.
Journal of Natural Medicines|June 22, 2026
Hochuekkito reversed poly(I:C)-induced anxiety-like behavior and reductions in hippocampal BDNF expression in miceTeppei Ueda, Yasuhisa Izushi, Soichiro Ushio, et al.
Biological & Pharmaceutical Bulletin|May 2, 2017
DJ-1/PARK7: A New Therapeutic Target for Neurodegenerative DisordersMasanori Hijioka, Masatoshi Inden, Daijiro Yanagisawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 3, 2012
[Development of advanced educational programs, including research programs, for undergraduate students in National Universities: the facts in 2010]Yuji Kurosaki, Yoshihisa Tomioka, Tomofumi Santa, et al.
Journal of Pharmaceutical Health Care and Sciences|January 29, 2016
Effectiveness of medical supportive team for outpatients treated with sorafenib: a retrospective studyMakoto Kajizono, Megumu Aoyagi, Yoshihisa Kitamura, et al.
Brain Sciences|February 25, 2022
Lipoxin A<sub>4</sub> Receptor Stimulation Attenuates Neuroinflammation in a Mouse Model of Intracerebral HemorrhageRisa Futokoro, Masanori Hijioka, Moe Arata, et al.
Acta Medica Okayama|August 27, 2020
Immobility-reducing Effects of Ketamine during the Forced Swim Test on 5-HT1A Receptor Activity in the Medial Prefrontal Cortex in an Intractable Depression ModelKei Takahashi, Yoshihisa Kitamura, Soichiro Ushio, et al.
Pharmacology, Biochemistry, and Behavior|March 20, 2002
Effects of imipramine and lithium on wet-dog shakes mediated by the 5-HT2A receptor in ACTH-treated ratsYoshihisa Kitamura, Hiroaki Araki, Katsuya Suemaru, et al.
Neurochemical Research|May 10, 2003
Neuroprotective mechanisms of antiparkinsonian dopamine D2-receptor subfamily agonistsYoshihisa Kitamura, Takashi Taniguchi, Shun Shimohama, et al.
Pageof 26